Therapeutic renaissance of thalidomide in the treatment of haematological malignancies.
about
Immunomodulatory drugs and active immunotherapy for chronic lymphocytic leukemiaBone marrow angiogenesis in multiple myeloma.The role of microenvironment in tumor angiogenesis.The role of angiogenesis in human non-Hodgkin lymphomas.Putative effects of potentially anti-angiogenic drugs in rheumatic diseases.Insights into the molecular roles of heparan sulfate proteoglycans (HSPGs-syndecans) in autocrine and paracrine growth factor signaling in the pathogenesis of Hodgkin's lymphoma.Role of Endothelial Cells and Fibroblasts in Multiple Myeloma Angiogenic Switch.Epstein-Barr virus positivity is associated with angiogenesis in, and poorer survival of, patients receiving standard treatment for classical Hodgkin's lymphoma.Thalidomide inhibits leukemia cell invasion and migration by upregulation of early growth response gene 1.The history of angiogenesis inhibitors.
P2860
Q27001318-69DD0709-FB13-41F5-A6F2-9C8026527455Q36343529-1B2C4F2A-7901-49D2-8533-E07CFECE2A7BQ36558575-C3CE1521-B673-4E42-8FD5-805034EAB7B5Q36670881-C7E8E0BA-5DA6-4449-AC38-BE2EE3AF7B56Q38160325-169276B2-2207-486C-BCAF-DCC6E38E6E3AQ38868904-C6BFEF72-1969-4FD7-AA55-EEE0AE268FE1Q38970580-E44BFF2E-4493-477C-95D3-F49620796591Q40108143-BF159EAC-A697-4B61-BBF1-2AC319807BDAQ45942658-FAEC126C-B63A-4053-8F00-50C137272290Q53184010-C28D20FC-0442-48F9-8228-9E0E062CBC1D
P2860
Therapeutic renaissance of thalidomide in the treatment of haematological malignancies.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Therapeutic renaissance of thalidomide in the treatment of haematological malignancies.
@ast
Therapeutic renaissance of thalidomide in the treatment of haematological malignancies.
@en
type
label
Therapeutic renaissance of thalidomide in the treatment of haematological malignancies.
@ast
Therapeutic renaissance of thalidomide in the treatment of haematological malignancies.
@en
prefLabel
Therapeutic renaissance of thalidomide in the treatment of haematological malignancies.
@ast
Therapeutic renaissance of thalidomide in the treatment of haematological malignancies.
@en
P2860
P356
P1433
P1476
Therapeutic renaissance of thalidomide in the treatment of haematological malignancies.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.LEU.2403852
P577
2005-09-01T00:00:00Z